Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.01 USD | -2.91% | +0.25% | -30.62% |
29/05 | Transcript : BridgeBio Pharma, Inc. - Special Call | |
28/05 | UBS Adjusts Price Target on BridgeBio Pharma to $47 From $51, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.62% | 524.15Cr | |
-2.29% | 8.99TCr | |
-3.95% | 3.76TCr | |
-13.07% | 3.28TCr | |
+63.05% | 2.65TCr | |
-22.14% | 1.43TCr | |
-7.96% | 1.3TCr | |
-9.33% | 1.19TCr | |
-46.33% | 1.08TCr | |
+5.77% | 911.12Cr |
- Stock Market
- Equities
- BBIO Stock
- News BridgeBio Pharma, Inc.
- SVB Securities Adjusts BridgeBio Pharma Price Target to $26 From $20, Maintains Outperform Rating